Request a copy

Full Text

• Herroeder S, Schönherr ME, De Hert SG, Hollmann MW Magnesium: Essentials for anesthesiologists Anesthesiology 2011 114 971-993.
• Fawcett W, Haxby E, Male D. Magnesium: Physiology and pharmacology. Br J Anaesth 1999; 83:302-320. (Pubitemid 29361145)
• Fuchs-Buder T, Tassonyi E. Magnesium sulphate enhances residual neuromuscular block induced by vecuronium. Br J Anaesth 1996; 76:565-566.
• Fawcett W, Stone J. Recurarization in the recovery room following the use of magnesium sulphate. Br J Anaesth 2003; 91:435-438. (Pubitemid 37063366)
• Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol. Anesthesiology 1998; 5:1170-1182. (Pubitemid 28216859)
• Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. Anesthesiology 1997; 1:10-23. (Pubitemid 27043998)
• Eikermann M, Groeben H, Bünten B, Peters J. Fade of pulmonary function during residual neuromuscular blockade. Chest 2005; 127:1703-1709. (Pubitemid 46218798)
• Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: Increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2009; 110:1253-1260.
• Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107:130-137.
• Jenkinson D. The nature of the antagonism between calcium and magnesium ions at the neuromuscular junction. J Physiol 1957; 138:434-444.
• Del Castillo J, Engbaek L. The nature of the neuromuscular block produced by magnesium. J Physiol 1954; 124:370-384.
• Waud B, Waud D. The relation between the response to 'train-of-four' stimulation and receptor occlusion during competitive neuromuscular block. Anesthesiology 1972; 37:413-416.
• Fuchs-Buder T, Ziegenfuss T, Lysakowski K, Tassonyi E. Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: Dose-effect relationship of neostigmine. Br J Anaesth 1999; 82:61-65. (Pubitemid 29043130)
• Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: The Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808. (Pubitemid 47063004)
• Motamed C, Kirov K, Combes X, Duvaldestin P. Comparison between the Datex-Ohmeda M-NMT module and a force-displacement transducer for monitoring neuromuscular blockade. Eur J Anaesthesiol 2003; 20:467-469. (Pubitemid 36648171)
• Trager G, Michaud G, Deschamps S, Hemmerling TM. Comparison of phonomyography, kinemyography and mechanomyography for neuromuscular monitoring. Can J Anaesth 2006; 53:130-135.
• Dahaba AA, von Klobucar F, Rehak PH, List WF. The neuromuscular transmission module versus the relaxometer mechanomyograph for neuromuscular block monitoring. Anesth Analg 2002; 94:591-596. (Pubitemid 34177555)
• Isaka T, Suzuki T, Mizutani H, et al. Optimum intubating dose of rocuronium for short duration surgery in adult patients. Masui 2010; 59:160-163.
• Sparr HJ, Beaufort TM, Fuchs-Buder T. Newer neuromuscular blocking agents: How do they compare with established agents? Drugs 2001; 61:919-942. (Pubitemid 32575394)